Characterisation of the antibacterial properties of a bacterial derived peptidoglycan hydrolase (LysCs4), active against C. sakazakii and other Gram-negative food-related pathogens

International Journal of Food Microbiology

Volumn 215, Issue , 2015, Pages 79-85

  Endersen, Lorraine ^a   Coffey, Aidan ^a   Ross, R Paul ^b   McAuliffe, Olivia ^c   Hill, Colin ^d   O'Mahony, Jim ^a  

^a Department of Chemistry   (Ireland)

^b UNIVERSITY COLLEGE CORK   (Ireland)

^c TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^d UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

Bacterial derived peptidoglycan hydrolase; Cronobacter sakazakii; Gram negative peptidoglycan degradation

Indexed keywords

GLYCOSIDASE; HYDROLASE; LYSOZYME; PEPTIDOGLYCAN; PEPTIDOGLYCAN HYDROLASE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; BIOLOGICAL CONTROL AGENT; N ACETYLMURAMOYLALANINE AMIDASE;

ANTIBACTERIAL ACTIVITY; ARTICLE; ARTIFICIAL MILK; BACTERIOPHAGE; CONTROLLED STUDY; CRONOBACTER SAKAZAKII; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME PURIFICATION; FOOD CONTAMINATION; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HYDROLYSIS; MOLECULAR CLONING; NONHUMAN; PROTEIN FAMILY; SEQUENCE HOMOLOGY; BIOLOGICAL CONTROL AGENT; CELL WALL; CHEMISTRY; DRUG EFFECTS; ENTEROBACTERIACEAE INFECTIONS; ENZYMOLOGY; FOODBORNE DISEASES; GROWTH, DEVELOPMENT AND AGING; HUMAN; INFANT; ISOLATION AND PURIFICATION; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PHARMACOLOGY; PREVENTION AND CONTROL;

ANTI-BACTERIAL AGENTS; BIOLOGICAL CONTROL AGENTS; CATALYTIC DOMAIN; CELL WALL; CRONOBACTER SAKAZAKII; ENTEROBACTERIACEAE INFECTIONS; FOOD CONTAMINATION; FOODBORNE DISEASES; HUMANS; INFANT; INFANT FORMULA; MICROBIAL SENSITIVITY TESTS; MURAMIDASE; N-ACETYLMURAMOYL-L-ALANINE AMIDASE; PEPTIDOGLYCAN;

EID: 84940651529     PISSN: 01681605     EISSN: 18793460     Source Type: Journal    
DOI: 10.1016/j.ijfoodmicro.2015.08.007     Document Type: Article

References (54)

1. Altschul S.F., Madden T.L., Schäffer A.A., Zhang J., Zhang Z., Miller W., Lipman D.J. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25:3389-3402.
2. Angulo F.J., Heuer O.E., Hammerum A.M., Collignon P., Wegener H.C. Human health hazard from antimicrobial-resistant enterococci in animals and food. Clin. Infect. Dis. 2006, 43:911-916.
3. Archibald A., Hancock I., Harwood C. Cell wall structure, synthesis, and turnover. Bacillus Subtilis and Other Gram-positive Bacteria 1993, 381-410. American Society for Microbiology, Washington, DC.
4. Bar-Oz B., Preminger A., Peleg O., Block C., Arad I. Enterobacter sakazakii infection in the newborn. Acta Paediatr. 2001, 90:356-358.
5. Bigot B., Lee W.-J., McIntyre L., Wilson T., Hudson J., Billington C., Heinemann J. Control of Listeria monocytogenes growth in a ready-to-eat poultry product using a bacteriophage. Food Microbiol. 2011, 28:1448-1452.
6. Blättel V., Wirth K., Claus H., Schlott B., Pfeiffer P., König H. A lytic enzyme cocktail from Streptomyces sp. B578 for the control of lactic and acetic acid bacteria in wine. Appl. Microbiol. Biotechnol. 2009, 83:839-848.
7. Borie C., Albala I., Sànchez P., Sánchez M.L., Ramírez S., Navarro C., Morales M.A., Retamales J., Robeson J. Bacteriophage treatment reduces Salmonella colonization of infected chickens. Avian Dis. 2008, 52:64-67.
8. Bramley A., Foster R. Effects of lysostaphin on Staphylococcus aureus infections of the mouse mammary gland. Res. Vet. Sci. 1990, 49:120-121.
9. Briers Y., Volckaert G., Cornelissen A., Lagaert S., Michiels C.W., Hertveldt K., Lavigne R. Muralytic activity and modular structure of the endolysins of Pseudomonas aeruginosa bacteriophages ϕKZ and EL. Mol. Microbiol. 2007, 65:1334-1344.
10. Callewaert L., Walmagh M., Michiels C.W., Lavigne R. Food applications of bacterial cell wall hydrolases. Curr. Opin. Biotechnol. 2011, 22:164-171.
11. Cavadini C., Hertel C., Hammes W.P. Application of lysostaphin-producing lactobacilli to control staphylococcal food poisoning in meat products. J. Food Prot. 1998, 61:419-424.
12. CDC http://www.cdc.gov/cronobacter/technical.html.
13. Doolittle M., Cooney J., Caldwell D. Lytic infection of Escherichia coli biofilms by bacteriophage T4. Can. J. Microbiol. 1995, 41:12-18.
14. El-Shibiny A., Scott A., Timms A., Metawea Y., Connerton P., Connerton I. Application of a group II Campylobacter bacteriophage to reduce strains of Campylobacter jejuni and Campylobacter coli colonizing broiler chickens. J. Food Prot. 2009, 72:733-740.
15. Farmer J.J., Asbury M., Hickman F., Brenner D.J. Enterobacter sakazakii: a new species of "Enterobacteriaceae" isolated from clinical specimens. Int. J. Syst. Bacteriol. 1980, 30:569-584.
16. Forsythe S.J. Enterobacter sakazakii and other bacteria in powdered infant milk formula. Matern. Child Nutr. 2005, 1:44-50.
17. Friedemann M. Epidemiology of invasive neonatal Cronobacter (Enterobacter sakazakii) infections. Eur. J. Clin. Microbiol. Infect. Dis. 2009, 28:1297-1304.
18. Ghuysen J.-M., Tipper D.J., Strominger J.L. Enzymes that degrade bacterial cell walls. Methods Enzymol. 1966, 8:685-699.
19. Himelright I. Enterobacter sakazakii infections associated with the use of powdered infant formula-Tennessee, 2001. J. Am. Med. Assoc. 2002, 287:2204-2205.
20. Horton R.M., Hunt H.D., Ho S.N., Pullen J.K., Pease L.R. Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension. Gene 1989, 77:61-68.
21. Hungaro H.M., Mendonça R.C.S., Gouvêa D.M., Vanetti M.C.D., de Oliveira Pinto C.L. Use of bacteriophages to reduce Salmonella in chicken skin in comparison with chemical agents. Food Res. Int. 2013, 52:75-81.
22. Iversen C., Forsythe S. Isolation of Enterobacter sakazakii and other Enterobacteriaceae from powdered infant formula milk and related products. Food Microbiol. 2004, 21:771-777.
23. Kelly D., O'Sullivan O., Mills S., McAuliffe O., Ross R.P., Neve H., Coffey A. Genome sequence of the phage clP1, which infects the beer spoilage bacterium Pediococcus damnosus. Gene 2012, 504:53-63.
24. Labischinski H., Maidhof H., Franz M., Krüger D., Sidow T., Giesbrecht P. Biochemical and Biophysical Investigations Into the Cause of Penicillin-induced Lytic Death of Staphylococci: Checking Predictions of the Murosome Model 1988.
25. Lai M.-J., Lin N.-T., Hu A., Soo P.-C., Chen L.-K., Chen L.-H., Chang K.-C. Antibacterial activity of Acinetobacter baumannii phage ϕAB2 endolysin (LysAB2) against both Gram-positive and Gram-negative bacteria. Appl. Microbiol. Biotechnol. 2011, 90:529-539.
26. Lavigne R., Briers Y., Hertveldt K., Robben J., Volckaert G. Identification and characterization of a highly thermostable bacteriophage lysozyme. Cell. Mol. Life Sci. 2004, 61:2753-2759.
27. Leverentz B., Conway W.S., Alavidze Z., Janisiewicz W.J., Fuchs Y., Camp M.J., Chighladze E., Sulakvelidze A. Examination of bacteriophage as a biocontrol method for Salmonella on fresh-cut fruit: a model study. J. Food Prot. 2001, 64:1116-1121.
28. Leverentz B., Conway W.S., Camp M.J., Janisiewicz W.J., Abuladze T., Yang M., Saftner R., Sulakvelidze A. Biocontrol of Listeria monocytogenes on fresh-cut produce by treatment with lytic bacteriophages and a bacteriocin. Appl. Environ. Microbiol. 2003, 69:4519-4526.
29. Lim T.-H., Kim M.-S., Lee D.-H., Lee Y.-N., Park J.-K., Youn H.-N., Lee H.-J., Yang S.-Y., Cho Y.-W., Lee J.-B. Use of bacteriophage for biological control of Salmonella Enteritidis infection in chicken. Res. Vet. Sci. 2012, 93:1173-1178.
30. Loessner M.J., Rees C., Stewart G., Scherer S. Construction of luciferase reporter bacteriophage A511: luxAB for rapid and sensitive detection of viable Listeria cells. Appl. Environ. Microbiol. 1996, 62:1133-1140.
31. Nazarowec-White M., Farber J.M. Incidence, survival, and growth of Enterobacter sakazakii in infant formula. J. Food Prot. 1997, 60:226-230.
32. Obeso J.M., Martínez B., Rodríguez A., García P. Lytic activity of the recombinant staphylococcal bacteriophage ΦH5 endolysin active against Staphylococcus aureus in milk. Int. J. Food Microbiol. 2008, 128:212-218.
33. Oldham E.R., Daley M.J. Lysostaphin: use of a recombinant bactericidal enzyme as a mastitis therapeutic. J. Dairy Sci. 1991, 74:4175-4182.
34. Oliveira H., Azeredo J., Lavigne R., Kluskens L.D. Bacteriophage endolysins as a response to emerging foodborne pathogens. Trends Food Sci. Technol. 2012, 28:103-115.
35. Oliveira H., Thiagarajan V., Walmagh M., Sillankorva S., Lavigne R., Neves-Petersen M.T., Kluskens L.D., Azeredo J. A thermostable salmonella phage endolysin, Lys68, with broad bactericidal properties against Gram-negative pathogens in presence of weak acids. PLoS One 2014, 9.
36. Rivas L., Coffey B., McAuliffe O., McDonnell M.J., Burgess C.M., Coffey A., Ross R.P., Duffy G. In vivo and ex vivo evaluations of bacteriophages e11/2 and e4/1c for use in the control of Escherichia coli O157:H7. Appl. Environ. Microbiol. 2010, 76:7210-7216.
37. Rogers H., Perkins H., Ward J. The bacterial autolysins. Microbial Cell Walls and Membranes 1980, 437-460. Springer.
38. Royet J., Dziarski R. Peptidoglycan recognition proteins: pleiotropic sensors and effectors of antimicrobial defences. Nat. Rev. Microbiol. 2007, 5:264-277.
39. Rozema E.A., Stephens T.P., Bach S.J., Okine E.K., Johnson R.P., Stanford K., McAllister T.A. Oral and rectal administration of bacteriophages for control of Escherichia coli O157: H7 in feedlot cattle. J. Food Prot. 2009, 72:241-250.
40. Schmelcher M., Donovan D.M., Loessner M.J. Bacteriophage endolysins as novel antimicrobials. Future Microbiol 2012, 7:1147-1171.
41. Schultz J., Milpetz F., Bork P., Ponting C.P. SMART, a simple modular architecture research tool: identification of signaling domains. Proc. Natl. Acad. Sci. 1998, 95:5857-5864.
42. Shockman G., Höltje J.-V. Microbial peptidoglycan (murein) hydrolases. New Compr. Biochem. 1994, 27:131-166.
43. Smith T.J., Blackman S.A., Foster S.J. Autolysins of Bacillus subtilis: multiple enzymes with multiple functions. Microbiology 2000, 146:249-262.
44. Szweda P., Kotłowski R., Łacka I., Synowiecki J. Protective effect of lysostaphin from Staphylococcus simulans against growth of Staphylococcus aureus in milk and some other food products. J. Food Saf. 2007, 27:265-274.
45. Teuber M. Veterinary use and antibiotic resistance. Curr. Opin. Microbiol. 2001, 4:493-499.
46. Tomasz A. Building and breaking of bonds in the cell wall of bacteria-the role for autolysins. Microbial Cell Wall Synthesis and Autolysis 1984, 3-12. Elsevier Science Publishers, Amsterdam.
47. Viazis S., Akhtar M., Feirtag J., Diez-Gonzalez F. Reduction of Escherichia coli O157:H7 viability on leafy green vegetables by treatment with a bacteriophage mixture and trans-cinnamaldehyde. Food Microbiol. 2011, 28:149-157.
48. Vollmer W. Structural variation in the glycan strands of bacterial peptidoglycan. FEMS Microbiol. Rev. 2008, 32:287-306.
49. Vollmer W., Joris B., Charlier P., Foster S. Bacterial peptidoglycan (murein) hydrolases. FEMS Microbiol. Rev. 2008, 32:259-286.
50. Wagenaar J.A., Van Bergen M.A., Mueller M.A., Wassenaar T.M., Carlton R.M. Phage therapy reduces Campylobacter jejuni colonization in broilers. Vet. Microbiol. 2005, 109:275-283.
51. Wall R.J., Powell A.M., Paape M.J., Kerr D.E., Bannerman D.D., Pursel V.G., Wells K.D., Talbot N., Hawk H.W. Genetically enhanced cows resist intramammary Staphylococcus aureus infection. Nat. Biotechnol. 2005, 23:445-451.
52. Wall S.K., Zhang J., Rostagno M.H., Ebner P.D. Phage therapy to reduce preprocessing Salmonella infections in market-weight swine. Appl. Environ. Microbiol. 2010, 76:48-53.
53. Walmagh M., Boczkowska B., Grymonprez B., Briers Y., Drulis-Kawa Z., Lavigne R. Characterization of five novel endolysins from Gram-negative infecting bacteriophages. Appl. Microbiol. Biotechnol. 2013, 97:4369-4375.
54. Zimmer M., Vukov N., Scherer S., Loessner M.J. The murein hydrolase of the bacteriophage ϕ3626 dual lysis system is active against all tested Clostridium perfringens strains. Appl. Environ. Microbiol. 2002, 68:5311-5317.